Molecular characterization of a monoclonal antibody produced in response to a group C meningococcal polysaccharide peptide mimic

Molecular Immunology

Volumn 33, Issue 6, 1996, Pages 503-510

  Hutchins, Wendy A ^a   Adkins, Angela R ^a   Kieber Emmons, Thomas ^b   Westerink, M A Julie ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Anti anti idiotype; Idiotype; Neisseria meningitidis serogroup C polysaccharide; Peptide mimic; Sequence analysis; Vaccine

Indexed keywords

MENINGOCOCCUS VACCINE; MONOCLONAL ANTIBODY; POLYSACCHARIDE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; IMMUNIZATION; MENINGOCOCCEMIA; MOUSE; NEISSERIA MENINGITIDIS; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

ANIMALIA; MENINGOCOCCUS; NEISSERIA; NEISSERIA MENINGITIDIS SEROGROUP C;

EID: 0030130892     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/0161-5890(96)00012-0     Document Type: Article

References (56)

1. Anderson E. L., Bowers T., Mink C. M., Kennedy D. J., Belshe R. B., Harakeh H., Pais L., Holder P. and Carlone G. M. (1994) Safety and immunogenicity of meningococcal A and C polysaccharide conjugate vaccine in adults. Infect. Immun. 62, 3391-3395.
2. Beuvery E. C., Leussink A. B., Van Delft R. W., Tiesjema R. H. and Nagel J. (1982) Immunoglobulin M and G antibody responses and persistence of these antibodies in adults after vaccination with a combined meningococcal group A and group C polysaccharide vaccine. Infect. Immun. 37, 579-585.
3. Brossay L., Paradis G., Pepin A., Mourad W., Cote L. and Hebert J. (1993) Idiotype and anti-anti-idiotype antibodies to Neisseria gonorrhoeae lipooligosaccharides with bactericidal activity but no cross-reactivity with red blood cell antigens. J. Immun. 151, 234-243.
4. Carneiro J. and Stewart J. (1994) Rethinking "shape space": Evidence from simulated docking suggests that steric shape complementarity is not limiting for antibody-antigen recognition and idiotypic interactions. J. theor. Biol. 169, 391-402.
5. Carroll W. L., Adderson E. E., Quinn A. and Shackelford P. G. (1992) Immunoglobulin variable region gene expression in response to Haemophilus influenzae type b polysaccharide. J. infect. Dis. 165, S57-S61.
6. Casadevall A. and Scharff M. D. (1991) The mouse antibody response to infection with Cryptococcus neoformans: VH and VL usage in polysaccharide binding antibodies. J. exp. Med. 174, 151-160.
7. Caton A. J., Herlyn D., Ross A. H. and Koprowski H. (1990) Identical D region sequences expressed by murine monoclonal antibodies specific for a human tumor-associated antigen. J. Immun. 144, 1965-1968.
8. Ceesay S. J., Allen S. J., Menon A., Todd J. E., Cham K., Carlone G. M., Turner S. H., Gheesling L. L., DeWitt W., Plikaytis B. D. and Greenwood B. (1993) Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization. J. infect. Dis. 167, 1212-1216.
9. Cheng H. L., Sood A. K., Ward R. E., Kieber-Emmons T. and Kohler H. (1988) Structural basis of stimulatory anti-idiotypic antibodies. Molec. Immun. 25, 33-40.
10. Chien N. C., Roberts V. A., Giusti A. M., Scharff M. D. and Getzoff E. D. (1989) Significant structural and functional change of an antigen-binding site by a distant amino acid substitution: Proposal of a structural mechanism. Proc. natn. Acad. Sci. U.S.A. 86, 5532-5536.
11. Conger J. D., Sage H. J. and Corley R. B. (1989) Diversity in the available repertoire of murine antibodies reactive with bromelain-treated isologous erythrocytes. J. Immun. 143, 4044-4052.
12. Engvall E. and Perlman P. (1971) Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 8, 871-874.
13. Evans S. V., Rose D. R., To R., Young N. M., Bundle D. R. (1994) Exploring the mimicry of polysaccharide antigens by anti-idiotypic antibodies. The crystallization, molecular replacement, and refinement to 2.8 Å resolution of an idiotope-anti-idiotope Fab complex and of the unliganded anti-idiotope Fab. J. molec. Biol. 241, 691-705.
14. Fields B. A., Goldbaum F. A., Ysern X., Poljak R. J. and Mariuzza R. A. (1995) Molecular basis of antigen mimicry by an anti-idiotope. Nature 374, 739-742.
15. Frasch C. E. (1989) Vaccines for prevention of meningococcal disease. Clin. Microbiol. Rev. 2, S134-S138.
16. Garcia K. C., Desiderio S. V., Ronco P. M., Verroust P. J. and Amzel L. M. (1992) Recognition of angiotensin II: antibodies at different levels of an idiotypic network are superimposable. Science 257, 528-531.
17. Gheesling L. L., Carlone G. M., Pais L. B., Holder P. F., Maslanka S. E., Plikaytis B. D., Achtman M., Densen P., Frasch C. E., Kayhty H., Mays J. P., Nencioni L., Peeters C., Phipps D. C., Poolman J. T., Rosenqvist E., Siber G. R., Thiesen B., Tai J., Thompson C. M., Vella P. P. and Wenger J. D. (1994) Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbant assay. J. clin. Microbiol. 32, 1475-1482.
18. Granoff D. M., Anderson E. L., Osterholm M. T., Holmes S. J., McHugh J. E., Belshe R. B., Medley F. and Murphy T. V. (1992) Differences in immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. J. Pediatr. 121, 187-194.
19. Hawkes R., Niday E. and Gordon J. (1982) A dot-immunobinding assay for monoclonal and other antibodies. Analyt. Biochem. 119, 142-147.
20. Hoess R., Brinkmann U., Handel T. and Pastan I. (1993) Identification of a peptide which binds to the carbohydrate-specific monoclonal antibody B3. Gene 128, 43-49.
21. Iwasaki Y., Takabatake H., Shinji T., Monestier M. and Ferrone S. (1994) Structural profile of idiotype, anti-idiotype and anti-anti-idiotype monoclonal antibodies in the HLA-DQ3 antigenic system. Eur. J. Immun. 24, 2874-2881.
22. Jackson D. C. and Brown E. E. (1991) A synthetic peptide of influenza virus hemagglutinin as a model antigen and immunogen. Peptide Res. 4, 114-124.
23. Jackson L. A. and Wenger J. D. (1993) Laboratory-based surveillance for meningococcal disease in selected areas, United States, 1989-1991. MMWR CDC Surveill. Summ. 42, 21-30.
24. Jackson L. A., Schuchat A., Reeves M. W. and Wenger J. D. (1995) Serogroup C meningococcal outbreaks in the United States. An emerging threat. JAMA 273, 383-389.
25. Jerne N. K. (1974) Toward a network theory of the immune system. Ann. Immun. 125, 373-389
26. Kabat E. A., Wu T. T., Reid Miller M., Perry H. M. and Gottesman K. S. (1991) Sequence of Proteins of Immunological Interest, Fifth edition. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, Bethesda, MD.
27. Kennett R. (1979) Cell fusion. Meth. Enzymol. 59, 345-359.
28. Kieber-Emmons T., Ward M. M., Ward R. E. and Kohler H. (1987) Structural considerations in idiotype vaccine design. Monogr. Allergy 22, 126-133.
29. Kieber-Emmons T., Ward R. E., Raychaudhuri S., Rein R. and Kohler H. (1986) Rational design and application of idiotope vaccines. Int. Rev. Immun. 1, 1-26.
30. L regions of murine monoclonal antibodies against 3-fucosyl-lactosamine. J. Immun. 140, 1212-1217.
31. Kohler H., Kaveri S., Kieber-Emmons T., Morrow W. J., Muller S. and Raychaudhuri S. (1989) Idiotypic networks and nature of molecular mimicry: an overview. Meth. Enzymol. 178, 3-35.
32. Lowell G. H., Ballou W. R., Smith L. F., Wirtz R. A., Zollinger W. D. and Hockmeyer W. T. (1988) Proteosome-lipopeptide vaccines: enhancement of immunogenicity for malaria CS peptides. Science 240, 800-802.
33. Lowell G. H., Smith L. F., Seid R. C. and Zollinger W. D. (1988) Peptides bound to proteosomes via hydrophobic feet become highly immunogenic without adjuvants. J. exp. Med. 167, 658-663.
34. Mosier D. E., Mond J. J. and Goldings E. (1977) The ontogeny of thymic-independent antibody response in vitro in normal mice and mice with an X-linked B cell defect. J. Immun. 119, 1874-1878.
35. Mosier D. E., Zaldivar N. M., Goldings E., Mond J., Scher I. and Paul W. E. (1977) Formation of antibody in the newborn mouse: Study of T-cell independent antibody response. J. infect. Dis. 136, S14-S19.
36. Oldenburg K. R., Loganathan D., Goldstein I. J., Schultz P. G. and Gallop M. A. (1992) Peptide ligands for a sugar-binding protein isolated from a random peptide library. Proc. natn. Acad. Sci. U.S.A. 89, 5393-5397.
37. Otteson E. W., Welch W. H. and Kozel T. R. (1994) Protein-polysaccharide interactions. A monoclonal antibody specific for the capsular polysaccharide of Cryptococcus neoformans. J. biol. Chem. 269, 1858-1864.
38. Raychaudhuri S., Kang C. Y., Kaveri S. V., Kieber-Emmons T. and Kohler H. (1990) Tumor idiotype vaccines. VII. Analysis and correlation of structural, idiotypic, and biologic properties of protective and nonprotective Ab2. J. Immun. 145, 760-767.
39. Reingold A. L., Hightower A. W., Bolan G. A., Jones E. E., Tiendrebeogo H., Broome C. V., Ajello G. W., Adamsbaum C., Philips C. and Yada A. (1985) Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine. Lancet 2, 114-118.
40. K, and D regions used by anti-GAT antibodies and monoclonal antibodies produced after anti-idiotypic immunization. Proc. natn. Acad. Sci. U.S.A. 82, 4788-4792.
41. Rudikoff S. (1988) Antibodies to β(1,6)-D-galactan: proteins, idiotypes and genes. Immun. Rev. 105, 97-111.
42. Sacks D. L., Kelsoe G. H. and Sachs D. H. (1983) Induction of immune responses with anti-idiotypic antibodies: Implications for the induction of protective immunity. Springer Semin. Immunopath. 6, 79-97.
43. Sacks D. L., Kirchhoff L. V. and Hieny S., Sher A. (1985) Molecular mimicry of a carbohydrate epitope on a major surface glycoprotein of Trypanosoma cruzi by using anti-idiotypic antibodies. J. Immun. 135, 4155-4159
44. Sambrook J., Fritsch E. F. and Maniatis T. (1989) Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, New York.
45. Sanger F., Nicklen S. and Coulson A. R. (1977) DNA sequencing with chain terminating inhibitors. Proc. natn. Acad. Sci. U.S.A. 79, 5463-5467.
46. Schreiber J. R., Nixon K. L., Tosi M. F., Pier G. B. and Patawaran M. B. (1991) Anti-idiotype-induced, lipopolysaccharide-specific antibody response to Pseudomonas aeruginosa. II. Isotype and functional activity of the anti-idiotype-induced antibodies. J. Immun. 146, 188-193.
47. Schwartz B., Moore P. S. and Broome C. V. (1989) Global epidemiology of meningococcal disease. Clin. Microbiol. Rev. 2, S118-124.
48. Silverman G. J. and Lucas A. H. (1991) Variable region diversity in human circulating antibodies specific for the capsular polysaccharide of Haemophilus influenzae type b. Preferential usage of two types of VH3 heavy chains. J. clin. Invest. 88, 911-920.
49. Southern E. M. (1975) Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. molec. Biol. 98, 503-517.
50. Stark S. E. and Canton A. J. (1991) Antibodies that are specific for a single amino acid interchange in a protein epitope use structurally distinct variable regions. J. exp. Med. 174, 613-624.
51. Stein K. E. (1992) Thymus-independent and thymus dependent responses to polysaccharide antigens. J. infect. Dis. 165, S49-S52.
52. Twumasi P. A., Jr, Kumah S., Leach A., O'Dempsey T. J. D., Ceesay S. J., Todd J., Broome C. V., Carlone G. M., Pais L. B., Holder P. K., Plikaytis B. D. and Greenwood B. M. (1995) A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. J. infect. Dis. 171, 632-638.
53. Westerink M. A. J. and Giardina P. C. (1992) Anti-idiotype induced protection against Neisseria meningitidis serogroup C bacteremia. Microb. Pathog. 12, 19-26.
54. Westerink M. A. J., Campagnari A. A., Wirth M. A. and Apicella M. A. (1988) Development and characterization of an anti-idiotype antibody to the capsular polysaccharide of Neisseria meningitidis serogroup C. Infect. Immun. 56, 1120-1127.
55. Westerink M. A. J., Giardina P. C., Apicella M. A. and Kieber-Emmons T. (1995) Peptide mimicry of the meningococcal group C capsular polysaccharide. Proc. natn. Acad. Sci. U.S.A. 92, 4021-4021.
56. Zollinger W. D., Mandrell R. E., Griffiss J. M., Altieri P. and Berman S. (1979) Complex of meningococcal group B polysaccharide and type 2 outer membrane protein immunogens in man. J. clin. Invest. 63, 836-848.